EPRSQ : EPIRUS Biopharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-24 |
|---|---|---|---|---|
| 2023 | $0.0 | $0.0 | $0.0 | -24.38% |
| 2024 | $0.0 | $0.0 | $0.0 | -42.42% |
| 2025 | $0.0 | $0.0 | $0.0 | -42.47% |
| 2026 | $0.0 | $0.0 | $0.0 | -53.29% |
| 2027 | $0.0 | $0.0 | $0.0 | -57.57% |
| 2028 | $0.0 | $0.0 | $0.0 | -58.95% |
| 2029 | $0.0 | $0.0 | $0.0 | 11.1% |
| 2030 | $0.0 | $0.0 | $0.0 | 169.81% |
| 2031 | $0.0 | $0.0 | $0.0 | 271.25% |
| 2032 | $0.0 | $0.0 | $0.0 | 305.43% |
| 2033 | $0.0 | $0.0 | $0.0 | 309.67% |
From AI system, total return is 2366.52% from 4098 forecasts.
For EPIRUS Biopharmaceuticals stock forecast for 2023, 9 predictions are offered for each month of 2023 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2023 represents a -24.38%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2024 represents a -42.42%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2026, 12 predictions are offered for each month of 2026 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2026 represents a -53.29%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2028 represents a -58.95%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2031, 12 predictions are offered for each month of 2031 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2031 represents a 271.25%
increase from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2033 represents a 309.67%
increase from the last price of $9.99999974737875E-5.
Please, see more forecasts below.
EPIRUS Biopharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2021-11-22 | $.00 | 6.01% |
| 2021-11-23 | $.00 | 136.32% |
| 2021-11-24 | $.00 | 40.85% |
| 2021-11-25 | $.00 | -11.12% |
| 2021-11-26 | $.00 | -19.90% |
EPRSQ : Long term EPIRUS Biopharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $.00 , for 2024 Mar. is $.00 , for 2027 Mar. is $.00 , for 2028 Mar. is $.00 , for 2032 Mar. is $.00 , and for 2033 Mar. is $.00.
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $.00 | -12.05% |
| 2023 May. | $.00 | -9.52% |
| 2023 Jun. | $.00 | 0.51% |
| 2023 Jul. | $.00 | -2.13% |
| 2023 Aug. | $.00 | -2.83% |
| 2023 Sep. | $.00 | -2.52% |
| 2023 Oct. | $.00 | -3.96% |
| 2023 Nov. | $.00 | -4.25% |
| 2023 Dec. | $.00 | -4.36% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $.00 | -4.25% |
| 2024 Feb. | $.00 | -3.92% |
| 2024 Mar. | $.00 | -3.42% |
| 2024 Apr. | $.00 | -0.42% |
| 2024 May. | $.00 | 0.43% |
| 2024 Jun. | $.00 | 0.19% |
| 2024 Jul. | $.00 | -0.84% |
| 2024 Aug. | $.00 | -1.50% |
| 2024 Sep. | $.00 | -1.45% |
| 2024 Oct. | $.00 | -0.86% |
| 2024 Nov. | $.00 | 0.03% |
| 2024 Dec. | $.00 | 0.87% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $.00 | 1.48% |
| 2025 Feb. | $.00 | 1.80% |
| 2025 Mar. | $.00 | 1.85% |
| 2025 Apr. | $.00 | 1.67% |
| 2025 May. | $.00 | 1.13% |
| 2025 Jun. | $.00 | 0.43% |
| 2025 Jul. | $.00 | -0.19% |
| 2025 Aug. | $.00 | -0.72% |
| 2025 Sep. | $.00 | -1.63% |
| 2025 Oct. | $.00 | -4.39% |
| 2025 Nov. | $.00 | -9.10% |
| 2025 Dec. | $.00 | -6.60% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $.00 | -4.02% |
| 2026 Feb. | $.00 | -2.39% |
| 2026 Mar. | $.00 | -0.63% |
| 2026 Apr. | $.00 | 0.68% |
| 2026 May. | $.00 | 1.86% |
| 2026 Jun. | $.00 | 1.88% |
| 2026 Jul. | $.00 | 1.55% |
| 2026 Aug. | $.00 | 1.00% |
| 2026 Sep. | $.00 | 0.36% |
| 2026 Oct. | $.00 | -0.23% |
| 2026 Nov. | $.00 | -0.51% |
| 2026 Dec. | $.00 | -0.18% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $.00 | -0.18% |
| 2027 Feb. | $.00 | -1.13% |
| 2027 Mar. | $.00 | -3.09% |
| 2027 Apr. | $.00 | -3.71% |
| 2027 May. | $.00 | -2.65% |
| 2027 Jun. | $.00 | -2.42% |
| 2027 Jul. | $.00 | -1.89% |
| 2027 Aug. | $.00 | -1.35% |
| 2027 Sep. | $.00 | -0.83% |
| 2027 Oct. | $.00 | -0.45% |
| 2027 Nov. | $.00 | -0.24% |
| 2027 Dec. | $.00 | -0.14% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $.00 | -0.13% |
| 2028 Feb. | $.00 | -0.14% |
| 2028 Mar. | $.00 | -0.06% |
| 2028 Apr. | $.00 | 0.19% |
| 2028 May. | $.00 | 0.53% |
| 2028 Jun. | $.00 | 0.78% |
| 2028 Jul. | $.00 | 1.02% |
| 2028 Aug. | $.00 | 1.26% |
| 2028 Sep. | $.00 | 1.55% |
| 2028 Oct. | $.00 | 1.91% |
| 2028 Nov. | $.00 | 2.39% |
| 2028 Dec. | $.00 | 3.02% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $.00 | 3.89% |
| 2029 Feb. | $.00 | 5.20% |
| 2029 Mar. | $.00 | 7.14% |
| 2029 Apr. | $.00 | 9.97% |
| 2029 May. | $.00 | 13.94% |
| 2029 Jun. | $.00 | 18.83% |
| 2029 Jul. | $.00 | 23.48% |
| 2029 Aug. | $.00 | 25.95% |
| 2029 Sep. | $.00 | 24.89% |
| 2029 Oct. | $.00 | 20.05% |
| 2029 Nov. | $.00 | 13.55% |
| 2029 Dec. | $.00 | 8.21% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $.00 | 5.09% |
| 2030 Feb. | $.00 | 3.37% |
| 2030 Mar. | $.00 | 2.52% |
| 2030 Apr. | $.00 | 2.14% |
| 2030 May. | $.00 | 2.02% |
| 2030 Jun. | $.00 | 1.98% |
| 2030 Jul. | $.00 | 2.00% |
| 2030 Aug. | $.00 | 2.11% |
| 2030 Sep. | $.00 | 2.33% |
| 2030 Oct. | $.00 | 2.76% |
| 2030 Nov. | $.00 | 3.25% |
| 2030 Dec. | $.00 | 3.59% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $.00 | 3.72% |
| 2031 Feb. | $.00 | 3.68% |
| 2031 Mar. | $.00 | 3.51% |
| 2031 Apr. | $.00 | 3.24% |
| 2031 May. | $.00 | 2.85% |
| 2031 Jun. | $.00 | 2.37% |
| 2031 Jul. | $.00 | 1.86% |
| 2031 Aug. | $.00 | 1.40% |
| 2031 Sep. | $.00 | 1.03% |
| 2031 Oct. | $.00 | 0.75% |
| 2031 Nov. | $.00 | 0.57% |
| 2031 Dec. | $.00 | 0.44% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $.00 | 0.36% |
| 2032 Feb. | $.00 | 0.31% |
| 2032 Mar. | $.00 | 0.27% |
| 2032 Apr. | $.00 | 0.23% |
| 2032 May. | $.00 | 0.21% |
| 2032 Jun. | $.00 | 0.20% |
| 2032 Jul. | $.00 | 0.20% |
| 2032 Aug. | $.00 | 0.19% |
| 2032 Sep. | $.00 | 0.17% |
| 2032 Oct. | $.00 | 0.15% |
| 2032 Nov. | $.00 | 0.13% |
| 2032 Dec. | $.00 | 0.10% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $.00 | 0.08% |
| 2033 Feb. | $.00 | 0.06% |
| 2033 Mar. | $.00 | 0.04% |
Frequently Asked Questions about EPIRUS Biopharmaceuticals stock forecast
Is EPIRUS Biopharmaceuticals a good long term stock?
From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to Tudal, the EPIRUS Biopharmaceuticals stock price forecast for 2023 Apr. is $8.79486108182235E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to Tudal, the EPIRUS Biopharmaceuticals stock price forecast for 2024 Mar. is $5.79426352565139E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to Tudal, the EPIRUS Biopharmaceuticals stock price forecast for 2027 Mar. is $4.55942236054583E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to Tudal, the EPIRUS Biopharmaceuticals stock price forecast for 2028 Mar. is $3.9560801228941E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock can be a good investment choice. According to Tudal, the EPIRUS Biopharmaceuticals stock price forecast for 2032 Mar. is $4.02716859201764E-4 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock can be a good investment choice. According to Tudal, the EPIRUS Biopharmaceuticals stock price forecast for 2033 Mar. is $4.09860412933636E-4
Is EPIRUS Biopharmaceuticals stock overvalued?
EPIRUS Biopharmaceuticals (EPRSQ) stock is expected to go DOWN . Therefore, Tudal would say that EPIRUS Biopharmaceuticals (EPRSQ) stock is overvalued.
Will EPIRUS Biopharmaceuticals stock price go up?
No. The EPIRUS Biopharmaceuticals stock price forecast for 2024 Mar. is $5.79426352565139E-5
Is EPIRUS Biopharmaceuticals stock a good buy now?
Since closing price on 2023-03-24 is $9.99999974737875E-5 and forecast for 2024 Mar. is $.00, EPIRUS Biopharmaceuticals stock is not a good 1 year investment.